<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36883137</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2772-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Healthcare analytics (New York, N.Y.)</Title><ISOAbbreviation>Healthc Anal (N Y)</ISOAbbreviation></Journal><ArticleTitle>The stability analysis of a co-circulation model for COVID-19, dengue, and zika with nonlinear incidence rates and vaccination strategies.</ArticleTitle><Pagination><StartPage>100151</StartPage><MedlinePgn>100151</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.health.2023.100151</ELocationID><Abstract><AbstractText>This paper aims to study the impacts of COVID-19 and dengue vaccinations on the dynamics of zika transmission by developing a vaccination model with the incorporation of saturated incidence rates. Analyses are performed to assess the qualitative behavior of the model. Carrying out bifurcation analysis of the model, it was concluded that co-infection, super-infection and also re-infection with same or different disease could trigger backward bifurcation. Employing well-formulated Lyapunov functions, the model's equilibria are shown to be globally stable for a certain scenario. Moreover, global sensitivity analyses are performed out to assess the impact of dominant parameters that drive each disease's dynamics and its co-infection. Model fitting is performed on the actual data for the state of Amazonas in Brazil. The fittings reveal that our model behaves very well with the data. The significance of saturated incidence rates on the dynamics of three diseases is also highlighted. Based on the numerical investigation of the model, it was observed that increased vaccination efforts against COVID-19 and dengue could positively impact zika dynamics and the co-spread of triple infections.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Omame</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Federal University of Technology, Owerri, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Abdus Salam School of Mathematical Sciences, Government College University Katchery Road, Lahore 54000, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Mujahid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Government College University Katchery Road, Lahore 54000, Pakistan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Healthc Anal (N Y)</MedlineTA><NlmUniqueID>9918523186206676</NlmUniqueID><ISSNLinking>2772-4425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Backward bifurcation</Keyword><Keyword MajorTopicYN="N">Co-circulation</Keyword><Keyword MajorTopicYN="N">Lyapunov stability</Keyword><Keyword MajorTopicYN="N">Model fitting</Keyword><Keyword MajorTopicYN="N">Optimization</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>1</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36883137</ArticleId><ArticleId IdType="pmc">PMC9979858</ArticleId><ArticleId IdType="doi">10.1016/j.health.2023.100151</ArticleId><ArticleId IdType="pii">S2772-4425(23)00018-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brady O.J., Gething P.W., Bhatt S., Messina J.P., Brownstein J.S., Hoen A.G., et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl. Trop. Dis. 2012;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3413714</ArticleId><ArticleId IdType="pubmed">22880140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Dick G.W., Kitchen S.F., Haddow A.J. Zika virus (I), isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 1952;46:509&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">12995440</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy M.R., Chen T.H., Hancock W.T., Powers A.M., Kool J.L., Lanciotti R.S., et al. Zika virus outbreak on Yap Island federated states of Micronesia. N. Engl. J. Med. 2009;360:2536&#x2013;2543. doi: 10.1056/NEJMoa0805715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0805715</ArticleId><ArticleId IdType="pubmed">19516034</ArticleId></ArticleIdList></Reference><Reference><Citation>Grard G., Caron M., Mombo I.M., Nkoghe D., Ondo S.Mboui., Jiolle D., et al. Zika virus in Gabon (Central Africa);2007: a new threat from Aedes albopictus. PLoS Negl. Trop. Dis. 2014;8 doi: 10.1371/journal.pntd.0002681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002681</ArticleId><ArticleId IdType="pmc">PMC3916288</ArticleId><ArticleId IdType="pubmed">24516683</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver S.C., Costa F., Garcia-Blanco M.A., Ko A.I., Ribeiro G.S., Saade G., et al. Zika virus: History emergence, biology, and prospects for control. Antiviral. Res. 2016;130:69&#x2013;80. doi: 10.1016/j.antiviral.2016.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.03.010</ArticleId><ArticleId IdType="pmc">PMC4851879</ArticleId><ArticleId IdType="pubmed">26996139</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos G.S., Bandeira A.C., Sardi S.I. Zika virus outbreak, bahia. Brazil. Emerg. Infect. Dis. 2015;21:1885&#x2013;1886. doi: 10.3201/eid2110.150847.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2110.150847</ArticleId><ArticleId IdType="pmc">PMC4593454</ArticleId><ArticleId IdType="pubmed">26401719</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria N.R., Quick J., Claro I.M., Theze J., Jesus JG.de., Giovanetti M., et al. Establishment and cryptic transmission of Zika virus in Brazil and the Americas. Nature. 2017;546:406&#x2013;410. doi: 10.1038/nature22401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22401</ArticleId><ArticleId IdType="pmc">PMC5722632</ArticleId><ArticleId IdType="pubmed">28538727</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., et al. Dengue: a continuing global threat. Nat. Rev,.Microbiol. 2010;8(Suppl.):S7&#x2013;S16. doi: 10.1038/nrmicro2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyamvada L., Quicke K.M., Hudson W.H., Onlamoon N., Sewatanon J., Edupuganti S., Pattanapanyasat K., Chokephaibulkit K., Mulligan M.J., Wilson P.C., Ahmed R., Suthar M.S., Wrammert J. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl. Acad. Sci. USA. 2016;113(28):7852&#x2013;7857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4948328</ArticleId><ArticleId IdType="pubmed">27354515</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul L.M., Carlin E.R., Jenkins M.M., Tan A.L., Barcellona C.M., Nicholson C.O., Michael S.F., Isern S. Dengue virus antibodies enhance Zika virus infection. Clin. Transl. Immunol. 2016;5(12):e117. doi: 10.1038/cti.2016.72. PMID: 28090318; PMCID: PMC5192063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2016.72</ArticleId><ArticleId IdType="pmc">PMC5192063</ArticleId><ArticleId IdType="pubmed">28090318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont-Rouzeyrol M., O&#x2019;Connor O., Calvez E., Daures M., John M., Grangeon J.P., A.C. Gourinat. Co-infection with Zika and Dengue viruses in 2 patients, New Caledonia 2014. Emerg. Infect. Dis. 2015;21(2):381&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313662</ArticleId><ArticleId IdType="pubmed">25625687</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B., Xiao Y., Wu J. Implication of vaccination against dengue for Zika outbreak. Sci. Rep. 2016;6:35623. doi: 10.1038/srep35623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35623</ArticleId><ArticleId IdType="pmc">PMC5075941</ArticleId><ArticleId IdType="pubmed">27774987</ArticleId></ArticleIdList></Reference><Reference><Citation>Gull A. WHO urges countries in dengue belt to look out for Zika. BMJ. 2016;352:i595.</Citation><ArticleIdList><ArticleId IdType="pubmed">26825803</ArticleId></ArticleIdList></Reference><Reference><Citation>Masyeni S., Santoso M.S., Widyaningsih P.D., Asmara D.W., Nainu F., Harapan H., Sasmono R.T. Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia. Int. J. Infect. Dis. 2021;102:152&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585717</ArticleId><ArticleId IdType="pubmed">33115680</ArticleId></ArticleIdList></Reference><Reference><Citation>Setiati T.E., Wagenaar J.F.P., Kruif M.de., Mairuhu A. Changing epidemiology of dengue haemorrhagic fever in Indonesia. Dengue Bull. 2006;30:1&#x2013;14.</Citation></Reference><Reference><Citation>Azhar A., Saeed U., Piracha Z.Z., Amjad A., Ahmed A., et al. SARS-CoV-2 related HIV HBV, RSV, VZV, enteric viruses, influenza, DENV, S. Aureus and TB coinfections. Arch Pathol Clin Res. 2021;5:026&#x2013;033.</Citation></Reference><Reference><Citation>Saddique A., Rana M.S., Alam M.M., Ikram A., Usman M., Salman M., Faryal R., Massab U., Bokhari H., Mian M.S., Israr&#xa0;A. Safiullah. Emergence of co-infection of COVID-19 and dengue: a serious public health threat. J Infect. 2020;81:16&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422859</ArticleId><ArticleId IdType="pubmed">32800797</ArticleId></ArticleIdList></Reference><Reference><Citation>2021. COVID-19: massive impact on lower-income countries threatens more disease outbreaks gavi, the vaccine alliance.  https://www.gavi.org/news/media-room/covid-19-massive-impact-lower-income-countries-threatens-more-disease-outbreaks. Accessed 07 2022.</Citation></Reference><Reference><Citation>Mohammed I., Nauman A., Paul P., Ganesan S., Chen K.H., Jalil S.M.S., Jaouni S.H., Kawas H., Khan W.A., Vattoth A.L., Al-Hashimi Y.A., Fares A., Zeghlache R., Zakaria D. The efficcy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum Vaccin Immunother. 2022;18(1):2027160. doi: 10.1080/21645515.2022.2027160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2027160</ArticleId><ArticleId IdType="pmc">PMC8862168</ArticleId><ArticleId IdType="pubmed">35113777</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayan G.H., Langevin E., Forrat R., Zambrano B., Noriega F., Frago C., Bouckenooghe A., Machabert T., Savarino S., DiazGranados C.A. Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus. Vaccine. 2020;38(41):6472&#x2013;6477. doi: 10.1016/j.vaccine.2020.07.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.07.056</ArticleId><ArticleId IdType="pubmed">32773243</ArticleId></ArticleIdList></Reference><Reference><Citation>2023. First dengue vaccine approved in more than 10 countries.  http://www/sanofipasteur.com/en/articles/first_dengue_vaccine_approved_in_more_than_10_countries.aspx. (Accessed January 2023)</Citation></Reference><Reference><Citation>Vannice K.S., Durbin A., Hombach J. Status of vaccine research and development of vaccines for dengue. Vaccine. 2016;34:2934&#x2013;2938.</Citation><ArticleIdList><ArticleId IdType="pubmed">26973072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng W., Halasa-Rappel Y.A., Baurin N., Coudeville L., Shepard D.S. Cost-effectiveness of dengue vaccination in ten endemic countries. Vaccine. 2018;36(3):413&#x2013;420. doi: 10.1016/j.vaccine.2017.11.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.11.064</ArticleId><ArticleId IdType="pubmed">29229427</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronel-Mart&#x131;nez D.L., Park J., L&#xf3;pez-Medina E., Capeding M.R., Cadena&#xa0;Bonfanti A.A., Montalb&#xe1;n M.C., Ram&#xed;rez I., Gonzales M.L.A., DiazGranados C.A., Zambrano B., Dayan G., Savarino S., Chen Z., Wang H., Sun S., Bonaparte M., Rojas A., Ram&#xed;rez J.C., Verdan M.A., Noriega F. Immunogenicity and safety of simplified vaccination schedules for the cyd-tdv dengue vaccine in healthy individuals aged 9-50 years (cyd65): a randomised, controlled, phase 2, non-inferiority study. Lancet Infect. Dis. 2021;21(4):517&#x2013;528. doi: 10.1016/S1473-3099(20)30767-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30767-2</ArticleId><ArticleId IdType="pubmed">33212067</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronel-Martinez D.L., Park J., L&#xf3;pez-Medina E., Capeding M.R., Bonfanti A.A.C., Montalb&#xe1;n M.C., Ram&#xed;rez I., Gonzales M.L.A., Zambrano B., Dayan G., Chen Z., Wang H., Bonaparte M., Rojas A., Ram&#xed;rez J.C., Verdan M.A., Noriega F. Immunogenicity and safety of booster cyd-tdv dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9-50 years: a randomised, controlled, phase 2, non-inferiority study. Lancet Infect Dis. 2022;22(6):901&#x2013;911. doi: 10.1016/S1473-3099(21)00706-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00706-4</ArticleId><ArticleId IdType="pubmed">35364022</ArticleId></ArticleIdList></Reference><Reference><Citation>Asamoah J.K.K., Okyere E., Abidemi A., Moore S.E., Sun G.-Q., Jin Z., Acheampong E., Gordon J.F. Optimal control and comprehensive cost-effectiveness analysis for COVID-19. Results Phys. 2022;33 doi: 10.1016/j.rinp.2022.105177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rinp.2022.105177</ArticleId><ArticleId IdType="pmc">PMC8760146</ArticleId><ArticleId IdType="pubmed">35070649</ArticleId></ArticleIdList></Reference><Reference><Citation>Asamoah J.K.K., Jin Z., Sun G.-Q. Non-seasonal and seasonal relapse model for q fever disease with comprehensive cost-effectiveness analysis. Results Phys. 2021;22 doi: 10.1016/j.rinp.2021.103889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rinp.2021.103889</ArticleId><ArticleId IdType="pmc">PMC8760146</ArticleId><ArticleId IdType="pubmed">35070649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukanwoke N.O., Okuonghae D., Inyama S.C. Modelling the dynamics of Zika in a population with two strains of the virus with optimal control and cost-effectiveness analysis. Int. J. Dynam. Control. 2022;10:956&#x2013;980. doi: 10.1007/s40435-021-00856-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40435-021-00856-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Hezam I.M. Covid-19 and chikungunya: an optimal control model with consideration of social and environmental factors. J. Ambient Intell. Hum. Comput. 2022 doi: 10.1007/s12652-022-03796-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12652-022-03796-y</ArticleId><ArticleId IdType="pmc">PMC8994927</ArticleId><ArticleId IdType="pubmed">35432621</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf T.T., Abidemi A. Effective strategies towards eradicating the tuberculosis epidemic: An optimal control theory alternative. Healthc. Anal. 2023;3 doi: 10.1016/j.health.2022.100131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.health.2022.100131</ArticleId></ArticleIdList></Reference><Reference><Citation>Umana R.A., Omame A., Inyama S.C. Deterministic and stochastic models of the dynamics of drug resistant tuberculosis. FUTO J. Ser. 2016;2(2):173&#x2013;194.</Citation></Reference><Reference><Citation>Din A. The stochastic bifurcation analysis and stochastic delayed optimal control for epidemic model with general incidence function. Chaos. 2021;31(12):123101. doi: 10.1063/5.0063050. PMID: 34972335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/5.0063050</ArticleId><ArticleId IdType="pubmed">34972335</ArticleId></ArticleIdList></Reference><Reference><Citation>Din A., Li A., Khan T., Zaman G. Mathematical analysis of spread and control of the novel corona virus (COVID-19) in China. Chaos, Solitons Fractals. 2020;141 doi: 10.1016/j.chaos.2020.110286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chaos.2020.110286</ArticleId><ArticleId IdType="pmc">PMC7510499</ArticleId><ArticleId IdType="pubmed">32989346</ArticleId></ArticleIdList></Reference><Reference><Citation>Addai E., Zhang L., Preko A.K., Asamoah JKK. Fractional order epidemiological model of SARS-CoV-2 dynamism involving Alzheimers disease. Healthc. Anal. 2022;2 doi: 10.1016/j.health.2022.100114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.health.2022.100114</ArticleId></ArticleIdList></Reference><Reference><Citation>Omame A., Okuonghae D. A co-infection model for oncogenic human papillomavirus and tuberculosis with optimal control and cost-effectiveness analysis. Opt. Contr. Appl. Meth. 2021;42(4):1081&#x2013;1101.</Citation></Reference><Reference><Citation>Din A., Amine S., Allali A. A stochastically perturbed co-infection epidemic model for COVID-19 and hepatitis B virus. Nonlinear Dyn. 2023;111(2):1921&#x2013;1945. doi: 10.1007/s11071-022-07899-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11071-022-07899-1</ArticleId><ArticleId IdType="pmc">PMC9517998</ArticleId><ArticleId IdType="pubmed">36193119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojo M.M., Benson T.O., Peter O.J., Goufo E.F.D. Nonlinear optimal control strategies for a mathematical model of COVID-19 and influenza co-infection. Physica A. 2022;607 doi: 10.1016/j.physa.2022.128173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physa.2022.128173</ArticleId><ArticleId IdType="pmc">PMC9461290</ArticleId><ArticleId IdType="pubmed">36106051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojo M.M., Goufo E.F.D. The impact of COVID-19 on a Malaria dominated region: A mathematical analysis and simulations. Alex. Eng. J. 2023;65:23&#x2013;39. doi: 10.1016/j.aej.2022.09.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aej.2022.09.045</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchoumi S.Y., Diagne M.L., Rwezaura H., Tchuenche J.M. Malaria and COVID-19 co-dynamics: A mathematical model and optimal control. Appl. Math. Model. 2021;99:294&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249695</ArticleId><ArticleId IdType="pubmed">34230748</ArticleId></ArticleIdList></Reference><Reference><Citation>Hye M.A., Biswas MA.H.A., Uddin M.F., Saifuddin M. Mathematical modeling of covid-19 and dengue co-infection dynamics in bangladesh: optimal control and data-driven analysis. Comput. Math. Model. 2022;33:173&#x2013;192. doi: 10.1007/s10598-023-09564-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10598-023-09564-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Omame A., Abbas M., Onyenegecha C.P. Backward bifurcation and optimal control in a co-infection model for SARS-CoV-2 and ZIKV. Results Phys. 2022;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994284</ArticleId><ArticleId IdType="pubmed">35433239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozkose&#xa0;F. Yavuz. Investigation of interactions between COVID-19 and diabetes with hereditary traits using real data: A case study in Turkey. Comput. Biol. Med. 2022;141 doi: 10.1016/j.compbiomed.2021.105044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.105044</ArticleId><ArticleId IdType="pubmed">34839902</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudiaby M.S., Gning L.D., Diagne M.L., Dia B.M., Rwezaura H., Tchuenche J.M. Optimal control analysis of a COVID-19 and tuberculosis co-dynamics model. Inform. Med. Unlocked. 2022;28</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8759807</ArticleId><ArticleId IdType="pubmed">35071729</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringa N., Diagne M.L., Rwezaura H., et al. HIV and COVID-19 co-infection: A mathematical model and optimal control. Inform. Med. Unlocked. 2022;31 doi: 10.1016/j.imu.2022.100978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2022.100978</ArticleId><ArticleId IdType="pmc">PMC9148865</ArticleId><ArticleId IdType="pubmed">35663416</ArticleId></ArticleIdList></Reference><Reference><Citation>Omame A., Isah M.E., Abbas M. An optimal control model for COVID-19, Zika, Dengue and Chikungunya co-dynamics with re-infection. Optim. Control Appl. Methods. 2022 doi: 10.1002/oca.2936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oca.2936</ArticleId><ArticleId IdType="pmc">PMC9538730</ArticleId><ArticleId IdType="pubmed">36248678</ArticleId></ArticleIdList></Reference><Reference><Citation>Olaniyi S. Dynamics of zika virus model with nonlinear incidence and optimal control strategies. Appl. Math. Inform. Sci. 2018;12(5):969&#x2013;982.</Citation></Reference><Reference><Citation>Okuonghae D. Backward bifurcation of an epidemiological model with saturated incidence, isolation and treatment functions. Qual. Theory Dyn. Syst. 2019;18:413&#x2013;440. doi: 10.1007/s12346-018-0293-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12346-018-0293-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidemi A., Owolabi K.M., Pindza E. Modelling the transmission dynamics of lassa fever with nonlinear incidence rate and vertical transmission. Physica A. 2022;597 doi: 10.1016/j.physa.2022.127259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physa.2022.127259</ArticleId></ArticleIdList></Reference><Reference><Citation>Opara C.Z., Uche-Iwe N., Inyama S.C., Omame A. A mathematical model and analysis of an SVEIR model for streptococcus pneumonia with saturated incidence force of infection. Math. Model. Appl. 2020;5(1):16&#x2013;38. doi: 10.11648/j.mma.20200501.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.11648/j.mma.20200501.13</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuneye K.O., Velasco-Hernandez J.X., Gumel A.B. The unholy Chikungunya-Dengue-Zika trinity: A theoretical analysis. J. Biol. Syst. 2017;25(4):545&#x2013;585.</Citation></Reference><Reference><Citation>Nowak M., May R.M. Superinfection and the evolution of parasite virulence. Proc. R. Soc. Lond. 1994;255:81&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">8153140</ArticleId></ArticleIdList></Reference><Reference><Citation>2022. https://www.citypopulation.de/en/brazil/regiaonorte/admin/13_amazonas/ (Accessed 13 June 2022).</Citation></Reference><Reference><Citation>Omame A., Okuonghae D., Nwajeri U.K., Onyenegecha C.P. A fractional-order multi-vaccination model for COVID-19 with non-singular kernel. Alex. Eng. J. 2022;61(8):6089&#x2013;6104. doi: 10.1016/j.aej.2021.11.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aej.2021.11.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson N.M., Laydon D., Nedjati-Gilani G., Imai N., Ainslie K., Baguelin M., Bhatia S., Boonyasiri A., Cucunub&#xe1; Z., Cuomo-Dannenburg G., et al. Imperial College COVID-19 Response Team; London: 2020. Impact of Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand, vol. 16.</Citation></Reference><Reference><Citation>United States Food and Drug Administration . 2020. Fda briefing document pfizer-biontech covid-19 vaccine.  https://www.fda.gov/media/144245/download. (Accessed 17 April 2022)</Citation></Reference><Reference><Citation>Driessche P.van.den., Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 2002;180(1):29&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">12387915</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo-Chavez C., Song B. Dynamical models of tuberculosis and their applications. Math. Biosci. Engnrg. 2004;2:361&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">20369977</ArticleId></ArticleIdList></Reference><Reference><Citation>LaSalle J.P. Regional Conferences Series in Applied Mathematics. SIAM; Philadelphia: 1976. The stability of dynamical systems.</Citation></Reference><Reference><Citation>Asamoah J.K.K., Owusu M.A., Jin Z., Oduro F.T., Abidemi A., Gyasi E.O. Global stability and cost-effectiveness analysis of covid-19 considering the impact of the environment:using data from ghana. Chaos Soliton Fractals. 2020;140:110103. doi: 10.1016/j.chaos.2020.110103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chaos.2020.110103</ArticleId><ArticleId IdType="pmc">PMC7351453</ArticleId><ArticleId IdType="pubmed">32834629</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidemi A., Ackora-Prah J., Fatoyinbo H.O., Asamoah J.K.K. Lyapunov stability analysis and optimization measures for a dengue disease transmission model. Physica A. 2022;602 doi: 10.1016/j.physa.2022.127646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physa.2022.127646</ArticleId></ArticleIdList></Reference><Reference><Citation>Blower S.M., Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model as an example. Int. Stat. Rev. 1994;2:229&#x2013;243.</Citation></Reference><Reference><Citation>McCall J. Genetic algorithms for modelling and optimisation. J. Comput. Appl. Math. 2005;184:205&#x2013;222.</Citation></Reference><Reference><Citation>https://coronalevel.com/Brazil/Amazonas/, (Accessed 13 June 2022).</Citation></Reference><Reference><Citation>http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinannet/cnv/denguebbr.def (Accessed 13 June 2022).</Citation></Reference><Reference><Citation>2022. http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinannet/cnv/zikabr.def (Accessed 13 June 2022).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>